Bio-Rad Laboratories, Inc. (BIO) Price/FCF Ratio: 22.43
Is Bio-Rad Laboratories, Inc.’s Price/FCF ratio high or low?
Bio-Rad Laboratories, Inc.'s Price/FCF ratio of 22.43 is 53% below its 5-year average of 47.61, near the low end of its 5-year range (18.23–186.64).
The Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO) is 22.43. It is above its 12-month average by 0.93% (22.22).
BIO Price/FCF Ratio Chart
BIO Average Price/FCF Ratio Chart
BIO Current vs Average Price/FCF Ratio Chart
BIO Price/FCF Ratio Metrics
PRICE/FCF RATIO
22.43
PRICE/FCF RATIO AVG TTM
22.22
PRICE/FCF RATIO AVG 3Y
39.72
PRICE/FCF RATIO AVG 5Y
47.61
PRICE/FCF RATIO AVG 10Y
109.65
PRICE/FCF RATIO AVG 15Y
84.63
PRICE/FCF RATIO AVG 20Y
72.66
CURRENT VS TTM AVG
+0.93%
CURRENT VS 3Y AVG
-43.53%
CURRENT VS 5Y AVG
-52.89%
CURRENT VS 10Y AVG
-79.54%
CURRENT VS 15Y AVG
-73.50%
CURRENT VS 20Y AVG
-69.13%
BIO Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | — | 22.43 | 22.22 | 39.72 | 47.61 |
| Charles River Laboratories International, Inc. (CRL) | $9.14B | 23.75 | 16.16 | 22.81 | 28.36 |
| Hims & Hers Health, Inc. (HIMS) | $6.46B | 87.26 | 77.36 | 70.86 | 70.86 |
| Align Technology, Inc. (ALGN) | $12.76B | 18.59 | 19.13 | 31.18 | 40.63 |
| Hologic, Inc. (HOLX) | $16.97B | 17.18 | 16.11 | 18.13 | 14.57 |
| Moderna, Inc. (MRNA) | $18.94B | 31.59 | 24.04 | 43.78 | 32.05 |
| BioNTech SE (BNTX) | $21.87B | 17.32 | 27.79 | 15.54 | 17.41 |
| Mettler-Toledo International Inc. (MTD) | $23.50B | 29.71 | 31.25 | 31.12 | 36.02 |
| Waters Corporation (WAT) | $24.19B | 115.48 | 39.81 | 39.29 | 38.33 |
| Veeva Systems Inc. (VEEV) | $27.37B | 53.69 | 30.57 | 33.96 | 39.47 |
Free Cash Flow Valuation
P/FCF Ratio
22.4
FCF Yield
4.46%
Bio-Rad Laboratories, Inc. Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. Price/FCF Ratio FAQ
- What is the Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The Price/FCF ratio for BIO stock is 22.43.
- Is Bio-Rad Laboratories, Inc.'s Price/FCF ratio high or low?
- Bio-Rad Laboratories, Inc.'s Price/FCF ratio of 22.43 is 53% below its 5-year average of 47.61, near the low end of its 5-year range (18.23–186.64).
- What is the TTM average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average Price/FCF ratio for BIO stock is 22.22.
- What is the 3Y average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average Price/FCF ratio for BIO stock is 39.72.
- What is the 5Y average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average Price/FCF ratio for BIO stock is 47.61.
- What is the 10Y average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average Price/FCF ratio for BIO stock is 109.65.
- What is the 15Y average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average Price/FCF ratio for BIO stock is 84.63.
- What is the 20Y average Price/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average Price/FCF ratio for BIO stock is 72.66.
Bio-Rad Laboratories, Inc. Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-03 | 23.01 |
| 2026-06-02 | 23.10 |
| 2026-06-01 | 23.05 |
| 2026-05-29 | 23.58 |
| 2026-05-28 | 24.02 |
| 2026-05-27 | 23.04 |
| 2026-05-26 | 22.41 |
| 2026-05-22 | 21.72 |
| 2026-05-21 | 21.64 |
| 2026-05-20 | 21.72 |
| 2026-05-19 | 21.21 |
| 2026-05-18 | 21.27 |
| 2026-05-15 | 18.68 |
| 2026-05-14 | 18.59 |
| 2026-05-13 | 18.38 |
| 2026-05-12 | 18.24 |
| 2026-05-11 | 18.40 |
| 2026-05-08 | 19.19 |
| 2026-05-07 | 19.42 |
| 2026-05-06 | 19.55 |
| 2026-05-05 | 19.40 |
| 2026-05-04 | 19.46 |
| 2026-05-01 | 19.36 |
| 2026-04-30 | 21.14 |
| 2026-04-29 | 19.84 |
| 2026-04-28 | 20.14 |
| 2026-04-27 | 20.72 |
| 2026-04-24 | 20.76 |
| 2026-04-23 | 20.29 |
| 2026-04-22 | 21.69 |
| 2026-04-21 | 22.04 |
| 2026-04-20 | 21.87 |
| 2026-04-17 | 21.56 |
| 2026-04-16 | 20.99 |
| 2026-04-15 | 21.34 |
| 2026-04-14 | 21.07 |
| 2026-04-13 | 20.78 |
| 2026-04-10 | 20.14 |
| 2026-04-09 | 20.01 |
| 2026-04-08 | 20.27 |
| 2026-04-07 | 20.05 |
| 2026-04-06 | 20.11 |
| 2026-04-02 | 20.19 |
| 2026-04-01 | 20.07 |
| 2026-03-31 | 20.10 |
| 2026-03-30 | 19.50 |
| 2026-03-27 | 19.14 |
| 2026-03-26 | 19.94 |
| 2026-03-25 | 19.73 |
| 2026-03-24 | 19.62 |
| 2026-03-23 | 19.11 |
| 2026-03-20 | 19.07 |
| 2026-03-19 | 19.11 |
| 2026-03-18 | 19.32 |
| 2026-03-17 | 19.43 |
| 2026-03-16 | 18.84 |
| 2026-03-13 | 18.95 |
| 2026-03-12 | 18.88 |
| 2026-03-11 | 19.46 |
| 2026-03-10 | 19.31 |
| 2026-03-09 | 19.57 |
| 2026-03-06 | 19.46 |
| 2026-03-05 | 20.12 |
| 2026-03-04 | 20.53 |
| 2026-03-03 | 20.20 |
| 2026-03-02 | 20.16 |
| 2026-02-27 | 20.08 |
| 2026-02-26 | 19.85 |
| 2026-02-25 | 19.44 |
| 2026-02-24 | 19.38 |
| 2026-02-23 | 19.34 |
| 2026-02-20 | 19.56 |
| 2026-02-19 | 19.61 |
| 2026-02-18 | 19.52 |
| 2026-02-17 | 19.10 |
| 2026-02-13 | 18.50 |
| 2026-02-12 | 21.09 |
| 2026-02-11 | 23.48 |
| 2026-02-10 | 23.98 |
| 2026-02-09 | 23.58 |
| 2026-02-06 | 24.10 |
| 2026-02-05 | 23.95 |
| 2026-02-04 | 24.46 |
| 2026-02-03 | 23.90 |
| 2026-02-02 | 23.78 |
| 2026-01-30 | 23.48 |
| 2026-01-29 | 23.58 |
| 2026-01-28 | 23.97 |
| 2026-01-27 | 23.80 |
| 2026-01-26 | 23.93 |
| 2026-01-23 | 23.71 |
| 2026-01-22 | 24.40 |
| 2026-01-21 | 24.91 |
| 2026-01-20 | 25.01 |
| 2026-01-16 | 25.07 |
| 2026-01-15 | 25.75 |
| 2026-01-14 | 25.44 |
| 2026-01-13 | 25.76 |
| 2026-01-12 | 25.82 |
| 2026-01-09 | 25.89 |
| 2026-01-08 | 25.51 |
| 2026-01-07 | 25.91 |
| 2026-01-06 | 26.02 |
| 2026-01-05 | 25.77 |
| 2026-01-02 | 24.41 |
| 2025-12-31 | 24.22 |
| 2025-12-30 | 24.35 |
| 2025-12-29 | 24.28 |
| 2025-12-26 | 24.30 |
| 2025-12-24 | 24.12 |
| 2025-12-23 | 24.07 |
| 2025-12-22 | 24.37 |
| 2025-12-19 | 24.11 |
| 2025-12-18 | 23.97 |
| 2025-12-17 | 24.09 |
| 2025-12-16 | 24.15 |
| 2025-12-15 | 24.62 |
| 2025-12-12 | 24.63 |
| 2025-12-11 | 25.10 |
| 2025-12-10 | 25.18 |
| 2025-12-09 | 24.63 |
| 2025-12-08 | 24.67 |
| 2025-12-05 | 25.40 |
| 2025-12-04 | 25.59 |
| 2025-12-03 | 25.61 |
| 2025-12-02 | 25.47 |
| 2025-12-01 | 25.70 |
| 2025-11-28 | 25.97 |
| 2025-11-26 | 26.15 |
| 2025-11-25 | 26.56 |
| 2025-11-24 | 25.78 |
| 2025-11-21 | 25.32 |
| 2025-11-20 | 24.27 |
| 2025-11-19 | 24.37 |
| 2025-11-18 | 24.61 |
| 2025-11-17 | 24.31 |
| 2025-11-14 | 25.04 |
| 2025-11-13 | 25.34 |
| 2025-11-12 | 26.17 |
| 2025-11-11 | 25.05 |
| 2025-11-10 | 24.58 |
| 2025-11-07 | 24.43 |
| 2025-11-06 | 24.51 |
| 2025-11-05 | 24.79 |
| 2025-11-04 | 24.86 |
| 2025-11-03 | 24.90 |
| 2025-10-31 | 25.55 |
| 2025-10-30 | 24.35 |
| 2025-10-29 | 25.54 |
| 2025-10-28 | 25.89 |
| 2025-10-27 | 26.33 |
| 2025-10-24 | 26.62 |
| 2025-10-23 | 26.53 |
| 2025-10-22 | 26.17 |
| 2025-10-21 | 25.95 |
| 2025-10-20 | 25.22 |
| 2025-10-17 | 24.29 |
| 2025-10-16 | 24.48 |
| 2025-10-15 | 23.96 |
| 2025-10-14 | 23.90 |
| 2025-10-13 | 23.80 |
| 2025-10-10 | 23.33 |
| 2025-10-09 | 23.55 |
| 2025-10-08 | 23.73 |
| 2025-10-07 | 23.23 |
| 2025-10-06 | 24.22 |
| 2025-10-03 | 23.94 |
| 2025-10-02 | 23.05 |
| 2025-10-01 | 23.34 |
| 2025-09-30 | 21.97 |
| 2025-09-29 | 21.16 |
| 2025-09-26 | 21.26 |
| 2025-09-25 | 21.19 |
| 2025-09-24 | 21.67 |
| 2025-09-23 | 22.10 |
| 2025-09-22 | 22.20 |
| 2025-09-19 | 22.26 |
| 2025-09-18 | 22.45 |
| 2025-09-17 | 21.96 |
| 2025-09-16 | 22.11 |
| 2025-09-15 | 21.95 |
| 2025-09-12 | 21.96 |
| 2025-09-11 | 22.40 |
| 2025-09-10 | 21.70 |
| 2025-09-09 | 22.40 |
| 2025-09-08 | 22.75 |
| 2025-09-05 | 23.15 |
| 2025-09-04 | 22.68 |
| 2025-09-03 | 22.57 |
| 2025-09-02 | 22.78 |
| 2025-08-29 | 23.34 |
| 2025-08-28 | 23.01 |
| 2025-08-27 | 22.94 |
| 2025-08-26 | 23.24 |
| 2025-08-25 | 23.30 |
| 2025-08-22 | 23.80 |
| 2025-08-21 | 22.33 |
| 2025-08-20 | 22.58 |
| 2025-08-19 | 22.59 |
| 2025-08-18 | 22.30 |
| 2025-08-15 | 22.38 |
| 2025-08-14 | 22.50 |
| 2025-08-13 | 22.50 |
| 2025-08-12 | 21.53 |
| 2025-08-11 | 20.73 |
| 2025-08-08 | 20.70 |
| 2025-08-07 | 20.78 |
| 2025-08-06 | 20.71 |
| 2025-08-05 | 21.33 |
| 2025-08-04 | 21.69 |
| 2025-08-01 | 22.30 |
| 2025-07-31 | 18.96 |
| 2025-07-30 | 21.05 |
| 2025-07-29 | 21.26 |
| 2025-07-28 | 21.32 |
| 2025-07-25 | 22.24 |
| 2025-07-24 | 22.06 |
| 2025-07-23 | 21.64 |
| 2025-07-22 | 20.66 |
| 2025-07-21 | 20.56 |
| 2025-07-18 | 20.74 |
| 2025-07-17 | 21.02 |
| 2025-07-16 | 20.81 |
| 2025-07-15 | 20.82 |
| 2025-07-14 | 21.11 |
| 2025-07-11 | 21.63 |
| 2025-07-10 | 21.88 |
| 2025-07-09 | 21.30 |
| 2025-07-08 | 21.11 |
| 2025-07-07 | 20.80 |
| 2025-07-03 | 21.18 |
| 2025-07-02 | 21.10 |
| 2025-07-01 | 20.88 |
| 2025-06-30 | 20.31 |
| 2025-06-27 | 20.54 |
| 2025-06-26 | 20.50 |
| 2025-06-25 | 20.29 |
| 2025-06-24 | 20.03 |
| 2025-06-23 | 19.83 |
| 2025-06-20 | 19.93 |
| 2025-06-18 | 19.53 |
| 2025-06-17 | 19.40 |
| 2025-06-16 | 19.50 |
| 2025-06-13 | 19.10 |
| 2025-06-12 | 19.57 |
| 2025-06-11 | 19.38 |
| 2025-06-10 | 19.41 |
| 2025-06-09 | 18.99 |
| 2025-06-06 | 18.47 |
| 2025-06-05 | 18.46 |
| 2025-06-04 | 18.69 |
| 2025-06-03 | 18.57 |
| 2025-06-02 | 18.23 |
| 2025-05-30 | 19.10 |
| 2025-05-29 | 19.16 |
| 2025-05-28 | 19.29 |
| 2025-05-27 | 19.39 |
| 2025-05-23 | 18.84 |
| 2025-05-22 | 19.12 |
| 2025-05-21 | 19.19 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz